5-hydroxytryptamine and neurotransmitter release in canine blood vessels. Inhibition by low and augmentation by high concentrations.
D000818:Animals; D001808:Blood Vessels / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D009994:Osmolar Concentration; D011188:Potassium / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects; D014439:Tyramine / Q000494:pharmacology
D018377:Neurotransmitter Agents; D012701:Serotonin; D011188:Potassium; D009638:Norepinephrine; D014439:Tyramine